Search Orphan Drug Designations and Approvals
-
| Generic Name: | Pramiracetam Sulfate |
|---|---|
| Date Designated: | 11/04/1991 |
| Orphan Designation: | For the management of cognitive dysfunction and enhancement of antidepressant activity associated with electroconvulsive therapy. |
| Orphan Designation Status: | Designated/Withdrawn |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Cambridge Neuroscience, Inc. 1 Kendall Square, Bldg. 700 Cambridge, Massachusetts 02139 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
-
